REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,941,000 | -18.4% | 29,496 | +1.1% | 0.01% | -30.0% |
Q4 2020 | $3,605,000 | +155.1% | 29,163 | +101.1% | 0.01% | +150.0% |
Q3 2020 | $1,413,000 | +447.7% | 14,499 | +15.2% | 0.00% | +300.0% |
Q1 2018 | $258,000 | -27.7% | 12,591 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $357,000 | -8.9% | 12,591 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $392,000 | -1.5% | 12,591 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $398,000 | +39.6% | 12,591 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $285,000 | – | 12,591 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |